Six of the tumors were originally diagnosed as LG-ESS, one as leiomyoma, one as leiomyosarcoma, and the last case (in which molecular testing was a part of the diagnostic work-up) as a sarcoma with the KAT6B::KANSL1 fusion. Here, KAT6B is linked to leiomyosarcoma.